ROSANO, GIUSEPPE MASSIMO CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.485
AS - Asia 2.063
EU - Europa 717
SA - Sud America 281
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 5.592
Nazione #
US - Stati Uniti d'America 2.348
SG - Singapore 689
CN - Cina 569
IT - Italia 314
TR - Turchia 285
VN - Vietnam 225
BR - Brasile 213
CA - Canada 106
DE - Germania 92
FR - Francia 90
HK - Hong Kong 68
UA - Ucraina 45
PK - Pakistan 44
GB - Regno Unito 40
IN - India 33
NL - Olanda 30
AR - Argentina 22
RU - Federazione Russa 22
PL - Polonia 21
BD - Bangladesh 20
MX - Messico 20
IL - Israele 19
ID - Indonesia 16
IQ - Iraq 15
JP - Giappone 13
CO - Colombia 12
EC - Ecuador 12
EU - Europa 11
IE - Irlanda 11
SA - Arabia Saudita 11
SE - Svezia 11
MY - Malesia 9
UZ - Uzbekistan 9
VE - Venezuela 9
ES - Italia 8
PH - Filippine 8
ZA - Sudafrica 8
FI - Finlandia 7
TW - Taiwan 6
BG - Bulgaria 5
KE - Kenya 5
TN - Tunisia 5
CL - Cile 4
HU - Ungheria 4
MA - Marocco 4
PY - Paraguay 4
AU - Australia 3
BO - Bolivia 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
RO - Romania 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
LT - Lituania 2
MN - Mongolia 2
NP - Nepal 2
PE - Perù 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
LI - Liechtenstein 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 5.592
Città #
San Jose 579
Ashburn 400
Dallas 371
Singapore 213
Rome 203
Santa Clara 157
Beijing 149
San Mateo 148
Kocaeli 145
Ho Chi Minh City 90
Toronto 85
Hong Kong 63
Frankfurt am Main 60
Houston 53
Shanghai 51
Hanoi 48
Chandler 44
Wilmington 41
Islamabad 36
São Paulo 32
Los Angeles 30
Guangzhou 29
Lawrence 28
Princeton 28
West Jordan 28
Chicago 23
Amsterdam 19
Netanya 17
Warsaw 17
Council Bluffs 16
New York 16
Boston 15
Seattle 15
Munich 13
Tokyo 12
Haiphong 11
Assago 10
Da Nang 10
Fairfield 10
Orem 10
Shenzhen 10
Atlanta 9
Brooklyn 9
Milan 9
Montreal 9
Rio de Janeiro 9
Buffalo 8
Manchester 8
Mexico City 8
Stockholm 8
Tashkent 8
Wandsworth 8
Woodbridge 8
Chennai 7
Johannesburg 7
Boardman 6
Cambridge 6
Kuala Lumpur 6
New Delhi 6
Roubaix 6
San Francisco 6
The Dalles 6
Wuhan 6
Biên Hòa 5
Campinas 5
Charlotte 5
Cremona 5
Dublin 5
Nairobi 5
Phoenix 5
Rui'an 5
Wuxi 5
Xi'an 5
Baghdad 4
Bexley 4
Brasília 4
Caracas 4
Jakarta 4
Jeddah 4
Ottawa 4
Paris 4
Pune 4
Santiago 4
São Gonçalo 4
Thái Bình 4
Verona 4
Wroclaw 4
Amman 3
Belo Horizonte 3
Casablanca 3
Cassino 3
Curitiba 3
Denver 3
Florence 3
Guayaquil 3
Helsinki 3
Hải Dương 3
Istanbul 3
Jinhua 3
London 3
Totale 3.643
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 132
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY 87
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect 80
Cellular Models for Understanding Adipogenesis, Adipose Dysfunction, and Obesity 79
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. 76
Essential role of ICAM-1 in aldosterone-induced atherosclerosis 73
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome 71
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 70
Anticoagulation in "real world" patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study 69
Androgens and cardiovascular disease: gender-related differences 68
Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay 67
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose 61
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 59
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 58
Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients 58
Effects of Nebivolol versus Carvedilol in Hypertensive Patients with Chronic Heart Failure 57
Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor 57
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 57
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism 54
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 54
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance 53
Endothelial effects of drugs designed to treat erectile dysfunction 53
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion 53
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? 53
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro 53
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction 53
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice 53
On-target antihypertensive treatment in Italy: The ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study 51
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs 50
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib 50
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure 50
Effect of exercise training on serum capacity to induce endothelial cell death in patients with chronic heart failure 49
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation 49
Drug Layering in Heart Failure: Phenotype-Guided Initiation 49
Vitamin D: a novel player in endothelial function and dysfunction 49
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? 49
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 47
Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients 47
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 46
Physical Training Reduces the Ability of Serum from Patients with Heart Failure to Induce Endothelial Cell Death 46
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients 45
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). 45
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model. 44
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation 44
Cardiac Metabolism in Myocardial Ischemia 44
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. 44
COMPARISON BETWEEN INTERVAL TRAINING AND ENDURAND TRAINING ON 24-H BLOOD PRESSURE AND GLUCOSE METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILURE: A PILOT STUDY 43
Estrogen acutely increases peripheral blood flow in postmenopausal women. 42
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. 42
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 42
Intensive cardiac rehabilitation improves glucometabolic state of non-diabetic patients with recent coronary artery bypass grafting 41
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology(ESC>) 41
Trimetazidine improves exercise performance in patients with peripheral arterial disease 41
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents 41
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT 40
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review 40
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. A 40
Hydrotherapy added to endurance training versus endurance training alone in elderly patients with chronic heart failure: A randomized pilot study. 40
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 39
Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. 39
Anabolic hormonal response to different exercise training intensities in men with chronic heart failure 39
Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. 39
Tricuspid annular plane systolic excursion is related to performance at six minute walking test in patients with heart failure undergoing exercise training. 39
Validation of rate of perceived exertion-based exercise training in patients with heart failure: Insights from autonomic nervous system adaptations. 38
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 38
Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure. 38
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 38
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology 38
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. 37
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 37
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 37
Ranolazine 37
Testosterone and heart failure. 36
Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment 36
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 36
Menopause and cardiovascular disease: the evidence. Rosano GM, Vitale C, Marazzi G, Volterrani M 36
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension. 36
MR antagonists protect against diet induced obesity and cardiac inflammation in mice, through browning of the adipose tissue and modulation of autophagy 36
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 36
Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77] 35
Clinical utility of ivabradine in cardiovascular disease management: current status 35
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure 35
Low testosterone levels are associated with coronary artery disease in male patients with angina. 34
Role of leucocyte count and thyroid-stimulating hormone in evolution of mild cognitive impairment to dementia 34
Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment 34
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review- From the Optimal Nutraceutical Supplementation in Heart Failure (Onus-HF) Working Group. 34
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. 34
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice 33
Comparison of Low-Dose Statin Versus Low-Dose Statin+Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial) 32
Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study Cohort. 31
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 31
Immunoregulation through extracellular nucleotides 31
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum 31
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. 31
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. 30
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology 29
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 29
Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease 29
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome 29
Inadequate Masking of Testosterone Reply 29
Totale 4.604
Categoria #
all - tutte 51.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 0 148 16
2021/2022288 1 82 83 8 0 0 18 28 5 58 2 3
2022/2023245 61 1 3 14 11 17 0 13 9 93 19 4
2023/2024343 4 0 10 32 9 14 1 22 4 59 14 174
2024/20251.247 93 287 50 30 49 174 57 68 187 17 58 177
2025/20263.268 268 246 298 311 264 327 568 214 364 371 37 0
Totale 5.749